Skip to main content
SpringerLink
Log in

Hypertrophic Cardiomyopathy: Usefulness of Imaging in Prognostic Stratification and Choice of Treatment

  • Chapter
  • First Online:
Clinical Echocardiography and Other Imaging Techniques in Cardiomyopathies

  • 1233 Accesses

Abstract

Cardiac imaging has an important role not only in the diagnosis of hypertrophic cardiomyopathy (HCM) but also in prognostic stratification. HCM is a disease with a variable course and outcome. Some cases are asymptomatic, with an excellent long-term survival, but some patients die suddenly or evolve toward a more severe disease, with heart failure (HF) and systolic function impairment. Cardiac imaging allows a thorough assessment of structural and functional features and identifies several risk factors to help the clinician discriminate severe disease from a more benign condition. Multiparametric imaging evaluation using echocardiography, cardiac magnetic resonance (CMR), and other techniques—such as positron emission tomography (PET)—increase the ability to stratify the outcome of these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Maron BJ, Maron MS (2013) Hypertrophic cardiomyopathy. Lancet 381(9862):242–255. doi:10.1016/S0140-6736(12)60397-3

    Article  PubMed  Google Scholar 

  2. O’Mahony C, Jichi F, Pavlou M, Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, McKenna WJ, Omar RZ, Elliott PM (2013) A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD). Eur Heart J. doi:10.1093/eurheartj/eht439

    Google Scholar 

  3. Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ (2000) Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 342(24):1778–1785. doi:10.1056/NEJM200006153422403

    Article  PubMed  CAS  Google Scholar 

  4. Elliott PM, Gimeno Blanes JR, Mahon NG, Poloniecki JD, McKenna WJ (2001) Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet 357(9254):420–424. doi:10.1016/S0140-6736(00)04005-8

    Article  PubMed  CAS  Google Scholar 

  5. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW (2011) 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 58(25):e212–e260. doi:10.1016/j.jacc.2011.06.011

    Article  PubMed  CAS  Google Scholar 

  6. Pinamonti B, Di Lenarda A, Nucifora G, Gregori D, Perkan A, Sinagra G (2008) Incremental prognostic value of restrictive filling pattern in hypertrophic cardiomyopathy: a Doppler echocardiographic study. Eur J Echocardiogr 9(4):466–471. doi:10.1016/j.euje.2007.06.008

    PubMed  Google Scholar 

  7. Biagini E, Spirito P, Rocchi G, Ferlito M, Rosmini S, Lai F, Lorenzini M, Terzi F, Bacchi-Reggiani L, Boriani G, Branzi A, Boni L, Rapezzi C (2009) Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy. Am J Cardiol 104(12):1727–1731. doi:10.1016/j.amjcard.2009.07.057

    Article  PubMed  Google Scholar 

  8. Kitaoka H, Kubo T, Hayashi K, Yamasaki N, Matsumura Y, Furuno T, Doi YL (2013) Tissue Doppler imaging and prognosis in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging 14(6):544–549. doi:10.1093/ehjci/jes200

    Article  PubMed  Google Scholar 

  9. Pagourelias ED, Efthimiadis GK, Parcharidou DG, Gossios TD, Kamperidis V, Karoulas T, Karvounis H, Styliadis IH (2011) Prognostic value of right ventricular diastolic function indices in hypertrophic cardiomyopathy. Eur J Echocardiogr 12(11):809–817. doi:10.1093/ejechocard/jer126

    Article  PubMed  Google Scholar 

  10. Lonborg JT, Engstrom T, Moller JE, Ahtarovski KA, Kelbaek H, Holmvang L, Jorgensen E, Helqvist S, Saunamaki K, Soholm H, Andersen M, Mathiasen AB, Kuhl JT, Clemmensen P, Kober L, Vejlstrup N (2013) Left atrial volume and function in patients following ST elevation myocardial infarction and the association with clinical outcome: a cardiovascular magnetic resonance study. Eur Heart J Cardiovasc Imaging 14(2):118–127. doi:10.1093/ehjci/jes118

    Article  PubMed  Google Scholar 

  11. Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ (2001) Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 104(21):2517–2524

    Article  PubMed  CAS  Google Scholar 

  12. Nistri S, Olivotto I, Betocchi S, Losi MA, Valsecchi G, Pinamonti B, Conte MR, Casazza F, Galderisi M, Maron BJ, Cecchi F (2006) Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy). Am J Cardiol 98(7):960–965. doi:10.1016/j.amjcard.2006.05.013

    Article  PubMed  Google Scholar 

  13. Finocchiaro G, Pinamonti B, Merlo M, Brun F, Barbati G, Sinagra G (2012) Prognostic role of clinical presentation in symptomatic patients with hypertrophic cardiomyopathy. J Cardiovasc Med (Hagerstown) 13(12):810–818. doi:10.2459/JCM.0b013e328356a231

    Article  Google Scholar 

  14. Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, Nistri S, Cecchi F, Udelson JE, Maron BJ (2006) Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 114(21):2232–2239. doi:10.1161/CIRCULATIONAHA.106.644682

    Article  PubMed  Google Scholar 

  15. Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, Cecchi F, Maron BJ (2003) Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 348(4):295–303. doi:10.1056/NEJMoa021332

    Article  PubMed  Google Scholar 

  16. Elliott PM, Gimeno JR, Tome MT, Shah J, Ward D, Thaman R, Mogensen J, McKenna WJ (2006) Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. Eur Heart J 27(16):1933–1941. doi:10.1093/eurheartj/ehl041

    Article  PubMed  Google Scholar 

  17. Efthimiadis GK, Parcharidou DG, Giannakoulas G, Pagourelias ED, Charalampidis P, Savvopoulos G, Ziakas A, Karvounis H, Styliadis IH, Parcharidis GE (2009) Left ventricular outflow tract obstruction as a risk factor for sudden cardiac death in hypertrophic cardiomyopathy. Am J Cardiol 104(5):695–699. doi:10.1016/j.amjcard.2009.04.039

    Article  PubMed  Google Scholar 

  18. Olivotto I, Cecchi F, Poggesi C, Yacoub MH (2012) Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging. Circ Heart Fail 5(4):535–546. doi:10.1161/CIRCHEARTFAILURE.112.967026

    Article  PubMed  Google Scholar 

  19. Pinamonti B, Merlo M, Nangah R, Korcova R, Di Lenarda A, Barbati G, Sinagra G (2010) The progression of left ventricular systolic and diastolic dysfunctions in hypertrophic cardiomyopathy: clinical and prognostic significance. J Cardiovasc Med (Hagerstown) 11(9):669–677. doi:10.2459/JCM.0b013e3283383355

    Article  Google Scholar 

  20. Yacoub MH, Olivotto I, Cecchi F (2007) ‘End-stage’ hypertrophic cardiomyopathy: from mystery to model. Nat Clin Pract Cardiovasc Med 4(5):232–233. doi:10.1038/ncpcardio0859

    Article  PubMed  Google Scholar 

  21. O’Hanlon R, Grasso A, Roughton M, Moon JC, Clark S, Wage R, Webb J, Kulkarni M, Dawson D, Sulaibeekh L, Chandrasekaran B, Bucciarelli-Ducci C, Pasquale F, Cowie MR, McKenna WJ, Sheppard MN, Elliott PM, Pennell DJ, Prasad SK (2010) Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 56(11):867–874. doi:10.1016/j.jacc.2010.05.010

    Article  PubMed  Google Scholar 

  22. Green JJ, Berger JS, Kramer CM, Salerno M (2012) Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. JACC Cardiovasc Imaging 5(4):370–377. doi:10.1016/j.jcmg.2011.11.021

    Article  PubMed  Google Scholar 

  23. Alla VM, Koneru S, Hunter C, Mooss A (2012) LGE and the risk of sudden death in HCM. JACC Cardiovasc Imaging 5(7):761–762; author reply 762–763. doi:10.1016/j.jcmg.2012.05.004

  24. Adabag AS, Maron BJ, Appelbaum E, Harrigan CJ, Buros JL, Gibson CM, Lesser JR, Hanna CA, Udelson JE, Manning WJ, Maron MS (2008) Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 51(14):1369–1374. doi:10.1016/j.jacc.2007.11.071

    Article  PubMed  Google Scholar 

  25. Todiere G, Aquaro GD, Piaggi P, Formisano F, Barison A, Masci PG, Strata E, Bacigalupo L, Marzilli M, Pingitore A, Lombardi M (2012) Progression of myocardial fibrosis assessed with cardiac magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 60(10):922–929. doi:10.1016/j.jacc.2012.03.076

    Article  PubMed  Google Scholar 

  26. Olivotto I, Girolami F, Sciagra R, Ackerman MJ, Sotgia B, Bos JM, Nistri S, Sgalambro A, Grifoni C, Torricelli F, Camici PG, Cecchi F (2011) Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations. J Am Coll Cardiol 58(8):839–848. doi:10.1016/j.jacc.2011.05.018

    Article  PubMed  Google Scholar 

  27. Camici P, Chiriatti G, Lorenzoni R, Bellina RC, Gistri R, Italiani G, Parodi O, Salvadori PA, Nista N, Papi L et al (1991) Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 17(4):879–886

    Article  PubMed  CAS  Google Scholar 

  28. Olivotto I, Cecchi F, Gistri R, Lorenzoni R, Chiriatti G, Girolami F, Torricelli F, Camici PG (2006) Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy. J Am Coll Cardiol 47(5):1043–1048. doi:10.1016/j.jacc.2005.10.050

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, University Hospital of Trieste, Via P. Valdoni 7, Trieste, 34139, Italy

    Gherardo Finocchiaro, Bruno Pinamonti MD, Elena Abate, Marco Merlo & Giancarlo Vitrella

Authors
  1. Gherardo Finocchiaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bruno Pinamonti MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elena Abate
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marco Merlo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Giancarlo Vitrella
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gherardo Finocchiaro .

Editor information

Editors and Affiliations

  1. Cattinara University Hospital, Trieste, Italy

    Bruno Pinamonti

  2. Cattinara University Hospital, Trieste, Italy

    Gianfranco Sinagra

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Finocchiaro, G., Pinamonti, B., Abate, E., Merlo, M., Vitrella, G. (2014). Hypertrophic Cardiomyopathy: Usefulness of Imaging in Prognostic Stratification and Choice of Treatment. In: Pinamonti, B., Sinagra, G. (eds) Clinical Echocardiography and Other Imaging Techniques in Cardiomyopathies. Springer, Cham. https://doi.org/10.1007/978-3-319-06019-4_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-06019-4_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-06018-7

  • Online ISBN: 978-3-319-06019-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation